@article{JTD23368,
author = {Luis Jara-Palomares and Teresa Elias-Hernandez and Maria Isabel Asensio-Cruz and Samira Marin-Romero and Remedios Otero-Candelera},
title = {Towards a precision medicine in venous thromboembolism associated to lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 26},
year = {2018},
keywords = {},
abstract = {Oncological patients have a higher risk for venous thromboembolism (VTE) (1,2), and also have an elevated risk of VTE recurrence and bleeding (3-5). Actually, guidelines in oncological patients with VTE recommend anticoagulant treatment, although these recommendations are the same, irrespectively of cancer and VTE location (6-9).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23368}
}